UMESH C MISHRA

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease LANCASTER, PA NPI 1386918779

General Payments — all program years on this page

$1,132.71

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 57
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $286.40 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $286.4018

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $41.692
2019 $210.098
2020 $60.714
2021 $96.075
2022 $199.9011
2023 $237.859
2024 $286.4018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080712110 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $15.24 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081718508 Lexicon Pharmaceuticals, Inc. $22.56 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113930 Novartis Pharmaceuticals Corporation $27.64 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113932 Novartis Pharmaceuticals Corporation $3.70 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113934 Novartis Pharmaceuticals Corporation $30.45 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113936 Novartis Pharmaceuticals Corporation $29.45 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113944 Novartis Pharmaceuticals Corporation $5.06 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113946 Novartis Pharmaceuticals Corporation $4.58 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113948 Novartis Pharmaceuticals Corporation $29.83 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113950 Novartis Pharmaceuticals Corporation $25.15 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113952 Novartis Pharmaceuticals Corporation $1.81 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113954 Novartis Pharmaceuticals Corporation $1.35 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113960 Novartis Pharmaceuticals Corporation $24.59 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113968 Novartis Pharmaceuticals Corporation $24.18 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113970 Novartis Pharmaceuticals Corporation $1.33 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113972 Novartis Pharmaceuticals Corporation $2.14 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113978 Novartis Pharmaceuticals Corporation $34.54 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087113980 Novartis Pharmaceuticals Corporation $2.80 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.